Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shandong Xinhua Pharmaceutical Co

Shandong Xinhua Pharmaceutical Co
1943 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
000756 STOCK SYMBOL
$1.22 SHARE PRICE (As of Wednesday Closing)
Description

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It is one of the country's largest manufacturing and exporting bases in the chemical synthetic pharmaceuticals field. It operates the business through the following segments: Chemical bulk drugs, Reagents, Chemical and Medical intermediates and other products. The firm provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Primary Office
  • No.1 Lutai Avenue, High-tech Zone
  • Zibo, 255086
  • China

+86 153 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shandong Xinhua Pharmaceutical Co’s full profile, request a free trial.

Shandong Xinhua Pharmaceutical Co Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.88 - $1.65 $629M $1.28 $0.07 10.8M 622M

Shandong Xinhua Pharmaceutical Co Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 553,272 440,973 956,240 656,733
Revenue 821,276 787,248 668,208 602,772
EBITDA 64,223 102,536 93,428 70,210
Net Income 43,061 37,917 31,014 18,357
Total Assets 849,133 860,031 807,765 680,144
Total Debt 173,080 110,139 165,935 145,453
Public Fundamental Data provided by Morningstar, Inc. disclaimer